Laboratory
Relocation Services
Offer Total Solution
PerkinElmer Launches OneSource®
Laboratory Relocation
Worry-Free,
Total Solution
for All Aspects of Relocation
Regardless of OEM or Scope
WALTHAM, Mass. (Jan. 30, 2007) - PerkinElmer Inc.
(NYSE: PKI), a global leader in Health Sciences and Photonics, today announced
the introduction of its OneSource Laboratory Relocation service designed to
handle the complex and time-consuming burdens laboratories face when moving
equipment from one location to another.
The service is available globally to facilitate the move of
all laboratory equipment regardless of technology or manufacturer.
"OneSource can take care of every aspect of a
relocation to enable scientists to keep their focus on the science," said
Dr. Joseph Tehrani, global business leader, Multi-vendor Validation and
Relocation Solutions, PerkinElmer Life and Analytical Sciences.
"We take away the headaches - from pre-testing and
inspection of equipment before a move through shipping, set-up and
qualification testing." He added that the turnkey relocation service also
encompasses preventive maintenance; moving of chemicals and samples;
transportation; insurance; customs; and installation, qualification and
commissioning at the new location.
"We streamline the process for customers - whether
they're a large pharmaceutical company or a small contract lab," Tehrani
added.
"Customers have a single point of contact, a plan to
minimize downtime, strong communication and realize increased efficiencies
from PerkinElmer's proven approach."
"While any relocation is complex, organizations in
heavily regulated environments, such as pharmaceutical companies, have the
added need to document their process in a very deliberate fashion to ensure
continued compliance," Tehrani said. "That's no simple task,
particularly when working with customized equipment from multiple vendors. Our
experts remove this burden, enabling customers to focus on the pace and
precision of their research and testing."
For more information about OneSource and its personalized
relocation services, please send an e-mail to OneSource@perkinelmer.com.
Factors Affecting Future Performance
This press release contains "forward-looking"
statements within the meaning of the Private Securities Litigation Reform Act
of 1995, including, but not limited to, statements relating to estimates and
projections of future earnings per share and revenue growth and other
financial results, developments relating to our customers and end-markets, and
plans concerning business development opportunities. Words such as
"believes," "intends," "anticipates,"
"plans," "expects," "projects,"
"forecasts," "will" and similar expressions, and
references to guidance, are intended to identify forward-looking statements.
Such statements are based on management's current assumptions and expectations
and no assurances can be given that our assumptions or expectations will prove
to be correct. A number of important risk factors could cause actual results
to differ materially from the results described, implied or projected in any
forward-looking statements. These factors include, without limitation: (1) our
failure to introduce new products in a timely manner; (2) our ability to
execute acquisitions and license technologies, or to successfully integrate
acquired businesses and licensed technologies into our existing business or to
make them profitable; (3) our failure to protect adequately our intellectual
property; (4) the loss of any of our licenses or licensed rights; (5) our
ability to compete effectively; (6) fluctuation in our quarterly operating
results and our ability to adjust our operations to address unexpected
changes; (7) our ability to produce an adequate quantity of products to meet
our customers' demands; (8) our failure to maintain compliance with applicable
government regulations; (9) regulatory changes; (10) economic, political and
other risks associated with foreign operations; (11) our ability to retain key
personnel; (12) restrictions in our credit agreement; (13) our ability to
realize the full value of our intangible assets; and (14) other factors which
we describe under the caption "Risk Factors" in our most recent
annual report on Form 10-K and in our most recent quarterly report on Form
10-Q and in our other filings with the Securities and Exchange Commission. We
disclaim any intention or obligation to update any forward-looking statements
as a result of developments occurring after the date of this press release.
Other Information
Health Sciences end markets include genetic screening,
environmental, service, biopharma, and medical imaging. Photonics markets
include sensors and specialty lighting. PerkinElmer, Inc. is a global
technology leader driving growth and innovation in Health Sciences and
Photonics markets to improve the quality of life. The Company reported
revenues of $1.55 billion in 2006, has 8,500 employees serving customers in
more than 125 countries, and is a component of the S&P 500 Index.
Additional information is available through www.perkinelmer.com or
1-877-PKI-NYSE. For further information regarding PerkinElmer, please contact:
Media Contact: Ellen Wein (412) 456-0986
